Is Amgen Stock a Safe Bet in the Biotech Industry?
The biotech market is expanding steadily as new technology makes previously impossible medical breakthroughs a reality. Global biotech is forecasted to reach …
The biotech market is expanding steadily as new technology makes previously impossible medical breakthroughs a reality. Global biotech is forecasted to reach …
Since the release of Ozempic and its weight-loss counterpart for labeled use, Wegovy, the stock market has enthusiastically been buying companies involved in …
Telehealth company Hims & Hers (NYSE:HIMS) is familiar to most consumers from the virtual ubiquity of its radio, TV and online advertising. Operating as a …
Veeva Systems (NYSE:VEEV), a software solutions provider for the life sciences industry, has seen some weakness amid the slowdown in cloud market demand as …
Exchange-traded funds continue to dominate investors’ portfolios for good reason, they give buyers exposure to a wide range of assets and avoid …
Exchange-traded funds and mutual funds that track the S&P 500 have been the bedrock of countless portfolios. These investment vehicles allow buyers to …
Amgen Inc. (NASDAQ:AMGN) stock has been on an uptrend lately. The favorable price action can be attributed to encouraging outcomes from its injectable obesity …
Exchange-traded funds reached global assets under management of $11.5 trillion in 2023, a 25% year-over-year increase. While ETFs can be built to track the …
Retirees have typically turned to investment vehicles that are stable and relatively safe, such as bonds or CDs. Because of the stock market’s volatility, …
A $1 trillion market capitalization seemed like an unattainable benchmark just 30 years ago, yet now it’s not a matter of who but how many companies have …
Pharmaceutical major Eli Lilly (NYSE:LLY) has seen its stock rise by more than 110% over the past 12 months, allowing it to handily beat the market in what was …
The latest clinical trials reported by Viking Therapeutics sparked huge interest amid the growing hype around anti-obesity drugs, but how high can the stock …
Eli Lilly (NYSE:LLY) has been on an impressive run lately. The pharmaceutical stock has gained 77% in the last year and achieved record highs of over $635 …
The market rally in the first half of 2023 saw the S&P 500 up over 20% by July. But the fall season checked the bullish momentum and brought the …
Momentum investing has been one of the most significant investment trends of the past several years. Often associated with the meme stock phenomenon of 2021, …
According to an article published in The New England Journal of Medicine, the United States is only a few years away from witnessing a massive surge in the …
Stanley Druckenmiller is a top investor who has used his skills to shape a lucrative career – and build a massive fortune along the way. Though he is …
Medifast’s generous dividend has attracted the attention of investors – particularly since the company is a major player in the massive weight-loss …
Is Vanguard High Yield Dividend Index Fund Stock A Buy? Growth investors and income investors look at the market differently. Growth investors are focused on a …
In Q3, Stanley Druckenmiller’s Duquesne Family Office significantly rebalanced its portfolio and went on a large buying spree in the tech sector. …